- Latest Deal Type
- Financing Rounds
TFChem General Information
Developer of carbohydrate based drugs. The company is mainly engaged in drug discovery using fluorine atom properties to develop new glycomimetic compounds for the treatment of diabetes and obesity, enabling healthcare practitioners to use the compounds in various applications, such as cancer, diabetes, pain and inflammation and cardio-vascular diseases.
Corporate Backed or Acquired
- Voie de l'innovation
- Pharma Parc II Chaussée du Vexin
- 27100 Val de Reuil
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
TFChem Valuation & Funding
TFChem Former Investors
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|